Trials / Sponsors / Walden Biosciences
Walden Biosciences
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of WAL0921 in Patients With Glomerular Kidney Diseases Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease | Phase 2 | 2024-07-02 |
| Completed | Single Ascending Dose Study of WAL0921 in Healthy Subjects Healthy | Phase 1 | 2023-05-31 |